The Clorox Company $CLX Shares Acquired by Eliot Finkel Investment Counsel LLC

Eliot Finkel Investment Counsel LLC grew its holdings in shares of The Clorox Company (NYSE:CLX) by 157.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,115 shares of the company’s stock after purchasing an additional 19,030 shares during the period. Clorox makes up about 1.8% of Eliot Finkel Investment Counsel LLC’s portfolio, making the stock its 24th biggest holding. Eliot Finkel Investment Counsel LLC’s holdings in Clorox were worth $3,224,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Haverford Trust Co increased its position in Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after buying an additional 84 shares in the last quarter. Field & Main Bank raised its stake in Clorox by 3.3% in the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after buying an additional 100 shares during the last quarter. Golden State Wealth Management LLC boosted its holdings in Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after acquiring an additional 100 shares in the last quarter. Fisher Asset Management LLC boosted its holdings in Clorox by 1.7% in the third quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after acquiring an additional 102 shares in the last quarter. Finally, Kestra Private Wealth Services LLC grew its stake in shares of Clorox by 1.8% during the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock worth $617,000 after acquiring an additional 104 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Down 0.1%

Shares of CLX stock opened at $97.15 on Friday. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The firm has a market capitalization of $11.75 billion, a PE ratio of 15.77, a P/E/G ratio of 0.46 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock’s 50-day simple moving average is $94.22 and its 200-day simple moving average is $104.23.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on CLX shares. Citigroup cut their price objective on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 target price on shares of Clorox in a research note on Friday, May 1st. TD Cowen boosted their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. BNP Paribas Exane cut their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. Finally, Jefferies Financial Group decreased their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.